Skip to search formSkip to main contentSkip to account menu

Haemophilus B Conjugate Vaccine

Known as: Haemophilus influenzae b vaccine, Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-OMP), Haemophilus b oligosaccharide conjugate vacccine 
A vaccine against serotype b of the Gram-negative bacterium H. influenzae (Hib). Hib vaccines contain polysaccharide-protein conjugate antigens that… 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (3)

DTaP-Haemophilus influenzae type b conjugate vaccineHibTITER protein, Haemophilus influenzaePedvaxHIB
Vaccines, Conjugate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Lot-to-Lot Consistency of a Combined Hexavalent Diptheria-Tentanus-Acellular-Pertussis, Hepatitis B, Inactivated Polio and Haemophilus b Conjugate Vaccine, Adminstered to Healthy Chilean Infants at 2…
Objectives: To assess the safety, immunogenicity and lot consistency of a liquid hexavalent combined vaccine (DTaP-IPV-PRP~T-HBs… 
2003
2003
Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rates in a large west coast health maintenance organization
We evaluated the effect of introduction of a combined hepatitis B-Haemophilus influenzae b vaccine on vaccine coverage rates in a… 
Highly Cited
1998
Highly Cited
1998
Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of…
1996
1996
FDA approval of a Haemophilus b Conjugate Vaccine combined by reconstitution with an acellular pertussis vaccine.
  • MMWR. Morbidity and mortality weekly report
  • 1996
  • Corpus ID: 30448641
On September 27, 1996, the Food and Drug Administration (FDA) licensed a Haemophilus b Conjugate Vaccine (ActHIB) combined by… 
1995
1995
Combination Vaccines for Diphtheria, Tetanus, Pertussis, and Haemophilus influenzae Type b
The ability to combine the standard DTP and Haemophilus b conjugate vaccine considerably simplifies the childhood immunization… 
Highly Cited
1994
Highly Cited
1994
Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine.
Because inactivated poliovirus vaccine (IPV) and Haemophilus influenzae b vaccine are advised in many programs and may be… 
1993
1993
FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
  • MMWR. Morbidity and mortality weekly report
  • 1993
  • Corpus ID: 13110482
1993
1993
Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)
1991
1991
Haemophilus b disease after vaccination with Haemophilus b polysaccharide or conjugate vaccine.
The reported frequency of invasive Haemophilus influenzae type b disease occurring within 1 year after immunization was compared… 
1990
1990
Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease
Children younger than 2 years of age with previous invasive Haemophilus influenzae (Hib) type b disease may not develop… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)